Solian
4 customer reviewsSolian is an antipsychotic medicine containing amisulpride. It is for adults with schizophrenia or related psychotic disorders. It helps by balancing dopamine signalling to reduce hallucinations and delusions and support motivation at lower doses.
What is it?
Solian is a medicine used to treat schizophrenia and other conditions where a person loses touch with reality. It can reduce hallucinations and delusional thinking, and it can also help with social withdrawal and low drive in some patients.
One change clinicians focus on in 2026 is tailoring dose to symptom type, since the same medicine can behave differently at low versus higher doses in the dopamine system.
Composition
Solian contains amisulpride (you may also see it written as AMISULPIRID). Amisulpride binds mainly to dopamine D2 and D3 receptors; this reduces excessive dopamine activity in pathways linked to hallucinations and delusions, while lower-dose effects can support symptoms such as apathy and social withdrawal. Compared with many older antipsychotics, amisulpride has limited activity at several non-dopamine receptors, which can mean a different side-effect pattern for some people. [1]
How to use?
Take Solian exactly as your prescriber wrote it, at the same time(s) each day.
A practical way many patients stick to treatment is to link doses to fixed routines such as breakfast and bedtime, then use one simple reminder method (phone alarm or pill organiser). Swallow tablets with water; food is not usually a deciding factor, but consistency helps with nausea. If your plan uses split dosing, try to keep the interval stable day to day.
- Route: by mouth (tablets).
- Schedule: once daily or divided doses, based on the prescribed regimen.
- Duration: long-term for relapse prevention in many patients; stop or taper only under medical direction.
- Missed dose: take it when remembered if it’s still well before the next dose; if it’s close, skip and continue the next dose at the normal time.
- Do not stop suddenly: sudden discontinuation can bring rebound insomnia, agitation, and symptom return.
How does it work?
- Route: Oral (tablets)
- Adults with acute psychotic episodes: 400–800 mg once daily or in 2 divided doses; may increase up to 1200 mg/day if needed.
- Adults with predominantly negative symptoms: 50–300 mg once daily.
- Older adults: Start at the lowest effective dose; titrate slowly.
- Renal impairment: Reduce dose; typical guidance is 50% of usual dose if creatinine clearance 30–60 mL/min, one-third if 10–30 mL/min; avoid if <10 mL/min.
- Timing with food: Can be taken with or without meals.
- Duration: Use as prescribed for the treatment course; reassess regularly for ongoing need.
Indications
Solian is an antipsychotic medicine used to manage symptoms of schizophrenia and related psychotic disorders. It is used for adults who need help with hallucinations, delusions, disturbed thinking, agitation, or marked social withdrawal.
Comparison
Solian sits among “atypical” antipsychotics, but its receptor profile is more dopamine-selective than many peers.
| Option | How it’s often used | Trade-offs |
|---|---|---|
| Solian (amisulpride) | Schizophrenia; can help positive symptoms and sometimes negative symptoms | Higher prolactin risk in many patients; movement symptoms can occur |
| Risperidone | Broad use in psychosis and agitation | Prolactin rise and stiffness can also be common at higher doses |
| Olanzapine | Psychosis with prominent agitation or insomnia | Weight gain and metabolic effects often limit long-term use |
Doctors often choose based on the symptom pattern and what side effects the person has already struggled with. If libido problems or menstrual changes were a major issue on a prior medicine, clinicians may plan prolactin monitoring early with amisulpride rather than waiting for symptoms. If weight gain was the deal-breaker, they may avoid options known for stronger appetite effects, then build a follow-up plan around weight and glucose. WHO mental health guidance in 2025–2026 keeps emphasising continuity and adherence support as much as molecule choice, because relapse is frequently linked to treatment interruption rather than lack of drug effect. [4]
Contraindications
- Allergy or hypersensitivity to amisulpride or any component of Solian.
- Severe liver or kidney failure (dose adjustment or a different medicine may be needed).
- Pregnancy or breastfeeding, unless a specialist has judged that benefits outweigh risks for your situation.
- Use of other strong dopaminergic antagonists unless your prescriber has a clear, monitored rationale.
Not recommended for
Solian needs extra care in people with medical conditions that increase sensitivity to dopamine blockade, or in those taking medicines that affect heart rhythm and blood pressure.
Key precautions that matter in day-to-day life:
- Heart rhythm risk: antipsychotics can prolong QT in vulnerable patients; tell your prescriber if you have a history of fainting, known long-QT, or electrolyte problems.
- Kidney function: amisulpride is cleared mainly by the kidneys; reduced kidney function often means lower doses.
- Driving and machinery: sedation and slowed reaction time are common early on, even when you feel mentally calmer.
- Alcohol: alcohol can amplify sedation and impair judgement; this combination is a frequent cause of falls and missed doses.
Side effects
Side effects vary with dose, sensitivity, and whether you’re taking other medicines that also affect dopamine.
Commonly reported effects include sleepiness or fatigue, dizziness with low blood pressure, fast heartbeat, anxiety or irritability, tremor or muscle stiffness (dystonia), and weight gain. Some effects show up early (sleepiness, dizziness), while others develop over weeks (weight and appetite changes).
Serious effects are uncommon but clinically important: severe muscle stiffness with fever and confusion (a medical emergency), fainting or palpitations that could signal rhythm problems, and severe uncontrolled movements. Hormone-related effects from raised prolactin can include menstrual changes, breast swelling, milk discharge, and reduced libido; this is a frequent reason people quietly discontinue unless the prescriber asks directly. [2]
Two short truths help:
Sleepiness can be managed.
Common mistakes
People do not fail treatment because the medicine is “weak”; they usually fail it because of predictable, fixable problems.
- Stopping after early improvement. Psychosis can calm within days, but relapse risk rises when maintenance treatment is cut short.
- Changing the dose to manage side effects without telling the prescriber. This often triggers insomnia, anxiety, or symptom return.
- Taking the whole day’s dose late at night. For some, this worsens restlessness or vivid dreams.
- Ignoring early movement symptoms. Stiff jaw, neck pulling, or a new tremor can be treated early and does not need weeks of suffering.
- Not reporting sexual side effects or breast changes. These can be prolactin-related and worth addressing directly.
Doctor opinions
In practice, prescribers often describe amisulpride as a “clean” dopamine agent: it can settle persecutory ideas and auditory hallucinations without the heavy anticholinergic fog some patients feel on older antipsychotics. Dose selection matters more than many people expect, because low-dose strategies are sometimes used when the main burden is social withdrawal and blunted affect rather than agitation.
A pattern I’ve seen repeatedly is that side effects become manageable when the clinician actively asks about them using specific prompts—sleep, restlessness, sexual function, and breast changes—rather than waiting for the patient to volunteer sensitive symptoms. Another observation from routine care is that the first two weeks decide adherence: early drowsiness or akathisia can scare people into stopping, even when the medicine is starting to work. When follow-up is scheduled early and the plan is adjusted quickly, persistence improves.
Frequently asked questions
Some people notice reduced agitation and improved sleep within the first week, while delusions and hallucinations often take longer to settle. Functional improvement usually builds over several weeks with consistent dosing and follow-up. EMA assessment documents for amisulpride discuss this gradual pattern seen across trials and clinical use. [5]
Solian is primarily used for schizophrenia, and its role in bipolar disorder depends on the specific symptom picture and local prescribing practice. In real clinics, it may be considered when psychotic symptoms overlap with mood symptoms, or when other antipsychotics were poorly tolerated. WHO mental health guidance (2025–2026) frames antipsychotic choice as symptom-led and side-effect-led, rather than brand-led.
Weight gain can happen, and appetite changes may sneak up over weeks rather than days. People who monitor weight early often catch the trend before it becomes frustrating, and small routine changes can make a meaningful difference. For some patients, the bigger issue is fatigue reducing activity, so managing sedation can indirectly help weight control. NAFDAC patient-safety messaging in 2026 supports keeping follow-up appointments to detect these changes early.
The most clinically relevant risks are additive sedation (for example with alcohol or sedating medicines) and additive heart rhythm effects with QT-prolonging drugs. Dopamine-blocking combinations can also increase movement side effects, so prescribers usually avoid stacking similar antipsychotics unless there is a clear plan. EMA materials on antipsychotics and QT risk inform many local protocols used in hospital settings.
If you remember with enough time before the next scheduled dose, take the missed dose and return to your normal schedule. If it is close to the next dose, skip the missed dose rather than doubling up, since dose-doubling can increase dizziness, sedation, and movement symptoms. WHO medication-safety guidance stresses simple dosing rules to prevent accidental overuse in long-term treatment.
Yes. Amisulpride can raise prolactin, which may lead to menstrual irregularity, breast tenderness or discharge, erectile difficulties, and reduced libido. Many patients do not mention these effects unless asked directly, so bringing them up early helps the prescriber adjust treatment instead of losing adherence. EMA-reviewed safety information for amisulpride lists prolactin-related effects as a key counselling point.
Front view
Side view
Back view
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in. or 24x11x0.7 cm) and its contents cannot be seen.
Solian — Comparison with alternatives
Solian Current
Zyprexa Best price Best rated
Reviews and Experiences
Sources
- European Medicines Agency (EMA) (2026). Amisulpride: EPAR – Product Information and Clinical Overview. ↑
- World Health Organization (WHO) (2026). Management of psychotic disorders: pharmacological treatment and monitoring guidance. ↑
- National Agency for Food and Drug Administration and Control (NAFDAC) (2026). Medicine safety communication: keeping an accurate medication list and reporting adverse effects. ↑
- World Health Organization (WHO) (2025). mhGAP Intervention Guide: Psychosis module—updated guidance for antipsychotic use. ↑
- European Medicines Agency (EMA) (2026). Antipsychotics and QT prolongation: regulatory safety considerations for clinical practice. ↑